Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Second-generation schizont development refers to a specific stage in the intracellular life cycle of Eimeria species, responsible for coccidiosis. It involves asexual replication (schizogony), following initial infection and first-generation schizont formation. The first-generation merozoites invade new host cells to form second-generation schizonts, which contributes significantly to tissue damage during coccidial infections due to destruction of epithelial integrity. This stage is a potential focus for anticoccidial interventions.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Second-generation Eimeria Schizont Development (N/A).